Key Themes & Topics
Biologics Manufacturing Strategy
Next-Gen Upstream Processing
Downstream Purification Optimisation
AI & Data Analytics for Process Robustness
Building Future-Ready Biomanufacturing Capacity
Supply Chain Resilience and Logistics
John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
WHO
For Site Heads, Manufacturing VPs, and Engineering Directorsbased in the UK & Ireland, or global firms investing in the region's capacity.
WHAT
The premier operational gathering for the UK/IE biopharma hub, focusing on MHRA regulatory innovation, digital transformation, and capacity expansion.
WHY
To leverage the UK’s unique Point-of-Care framework and Ireland’s massive infrastructure growth to build a "Western Launchpad" for global biologics.
Senior Attendees
Meet a concentrated audience of Site Heads, Manufacturing VPs, and Engineering Directors from the UK & Ireland’s top biopharma hubs and investment projects.
Expert Speakers
Hear from world-class leaders in regulatory innovation (MHRA), facility design, digital manufacturing, and workforce development for the next generation of biologics.
Companies Represented
A gathering representing major global pharma investors, UK innovators, leading engineering firms, and technology providers building the future of British bioproduction.
Networking Hours
Connect with industry peers to discuss capacity expansion, regulatory compliance, and operational excellence in the UK and Ireland’s booming life sciences sector.
